These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 9233738

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients.
    Prielipp RC, Coursin DB, Scuderi PE, Bowton DL, Ford SR, Cardenas VJ, Vender J, Howard D, Casale EJ, Murray MJ.
    Anesth Analg; 1995 Jul; 81(1):3-12. PubMed ID: 7598277
    [Abstract] [Full Text] [Related]

  • 4. Randomised controlled trial comparing cisatracurium and vecuronium infusions in a paediatric intensive care unit.
    Burmester M, Mok Q.
    Intensive Care Med; 2005 May; 31(5):686-92. PubMed ID: 15815895
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [The clinical pharmacology of cisatracurium].
    Mellinghoff H, Diefenbach C.
    Anaesthesist; 1997 Jun; 46(6):481-5. PubMed ID: 9297378
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Recovery from neuromuscular blockade after either bolus and prolonged infusions of cisatracurium or rocuronium using either isoflurane or propofol-based anesthetics.
    Jellish WS, Brody M, Sawicki K, Slogoff S.
    Anesth Analg; 2000 Nov; 91(5):1250-5. PubMed ID: 11049917
    [Abstract] [Full Text] [Related]

  • 14. Phlebitis as a consequence of peripheral intravenous administration of cisatracurium besylate in critically ill patients.
    Meeder AM, van der Steen MS, Rozendaal A, van Zanten AR.
    BMJ Case Rep; 2016 Oct 03; 2016():. PubMed ID: 27698008
    [Abstract] [Full Text] [Related]

  • 15. Cisatracurium besilate. A review of its pharmacology and clinical potential in anaesthetic practice.
    Bryson HM, Faulds D.
    Drugs; 1997 May 03; 53(5):848-66. PubMed ID: 9129870
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Newer neuromuscular blocking agents: how do they compare with established agents?
    Sparr HJ, Beaufort TM, Fuchs-Buder T.
    Drugs; 2001 May 03; 61(7):919-42. PubMed ID: 11434449
    [Abstract] [Full Text] [Related]

  • 18. Tachyphylaxis associated with continuous cisatracurium versus pancuronium therapy.
    Kanji S, Barletta JF, Janisse JJ, Kruse JA, Devlin JW.
    Pharmacotherapy; 2002 Jul 03; 22(7):823-30. PubMed ID: 12126215
    [Abstract] [Full Text] [Related]

  • 19. Cisatracurium dosing in a patient with hyperthermia.
    Lim J, Cox J, Nguyen T, Arya R.
    Am J Health Syst Pharm; 2019 Jul 02; 76(14):1029-1032. PubMed ID: 31361873
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the pharmacodynamics and pharmacokinetics of an infusion of cis-atracurium (51W89) or atracurium in critically ill patients undergoing mechanical ventilation in an intensive therapy unit.
    Boyd AH, Eastwood NB, Parker CJ, Hunter JM.
    Br J Anaesth; 1996 Mar 02; 76(3):382-8. PubMed ID: 8785138
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.